CAESAREA, Israel – DarioHealth has received the Therapeutic Goods Administration Mark for an iPhone version of its Dario Blood Glucose Monitoring System in Australia. “We are thrilled that DarioHealth secured TGA approval to offer the Lightning-enabled version and can now accommodate users in Australia who have updated their Apple devices,” said Erez Raphael, CEO and chairman of DarioHealth, in a statement. “We hope to help the 1.7 million Australians who have diabetes, specifically the more than 100,000 Australians who have been diagnosed with diabetes in the past year.” In addition to the TGA approval, users in the U.K. are now able to purchase the Lightning-enabled Dario device, as well. DarioHealth is still waiting on approval from regulatory agencies in the U.S. and Canada, which is expected in the coming months.
You are here: / / DarioHealth receives TGA approval for iPhone-compatible BGM device in Australia